Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis

295Citations
Citations of this article
296Readers
Mendeley users who have this article in their library.

Abstract

Background: Sarcopenia is a common syndrome in chronic diseases such as liver cirrhosis. The association between sarcopenia and outcomes, such as complications and survival has recently been described in various patient groups. However, study results remain inconclusive. Therefore, the aim of this study was to systematically review the impact of sarcopenia on outcome in patients with cirrhosis. Methods and findings: We conducted a systematic review (SR) and meta-analysis (MA) on the impact of sarcopenia on outcome in liver cirrhosis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Of the 312 studies identified, 20 were eligible according to our inclusion criteria. Most of the studies used CT to diagnose sarcopenia. Two studies used bioelectrical impedance analysis (BIA), 10 studies used skeletal muscle index (SMI) and 8 studies used total psoas muscle area (TPA). Seven studies included Asian participants and the remaining 13 studies included Western participants. The prevalence rate of sarcopenia among participants was mean 48.1%, and appeared more among men with a rate of 61.6% whereas the rate was 36% for women. With respect to clinical outcomes, patients with sarcopenia had poorer survival rates and an increased risk of complications such as infection compared to those without sarcopenia. According to the analysis of race subgroup, Asians had a HR 2.45 (95% confidence interval (CI) = 1.44–4.16, P = 0.001) of mortality whereas Westerners had a HR 1.45 (95% CI = 1.002–2.09, P<0.05). Conclusions: Based on this SR and MA, the presence of sarcopenia is related to a poor prognosis and occurrence of cirrhotic complications and could be used for risk assessment. Moreover, Asian participants had higher mortality related to sarcopenia compared to the Western participants.

References Powered by Scopus

Quantifying heterogeneity in a meta-analysis

27112Citations
N/AReaders
Get full text

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

22657Citations
N/AReaders
Get full text

Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series

18136Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

400Citations
N/AReaders
Get full text

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

256Citations
N/AReaders
Get full text

Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis

240Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kim, G., Kang, S. H., Kim, M. Y., & Baik, S. K. (2017). Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS ONE, 12(10). https://doi.org/10.1371/journal.pone.0186990

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 75

58%

Researcher 34

26%

Professor / Associate Prof. 16

12%

Lecturer / Post doc 5

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 102

76%

Nursing and Health Professions 21

16%

Agricultural and Biological Sciences 8

6%

Pharmacology, Toxicology and Pharmaceut... 4

3%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free